In Practice: GP24 early bird registration extended Due to popular demand, the discounted registrations for the Perth conference have been extended to 7 October.
Government defers CDM Medicare item changes The concerns of GPs have been listened to, resulting in the Commonwealth delaying chronic disease management funding changes to 1 July next year.
‘Extremely concerned’: Frustration boils over amid CDM uncertainty The RACGP has demanded the Federal Government delay chronic disease management changes until funding details are clarified.
Mounjaro expanded to include weight management The TGA has approved tirzepatide for the treatment of overweight and obesity for those with comorbidities, via private prescription.
RACGP questions chronic disease funding ‘vacuum of information’ The Commonwealth has dropped new details about the revised MBS framework, but a persistent lack of funding details has GPs concerned.
Funding boost for ‘shared care model’ to improve diabetes outcomes The Australian-first trial will see general practices collaborate with exercise physiologists to improve outcomes for patients with type 2 diabetes.
Study links semaglutide and suicidal ideation risk There are calls for urgent investigation into its impact on mental health, but GPs are urging caution when interpreting the research.
CDM funding must be retained: RACGP The college is calling on the Government to guarantee there will be no funding losses when MBS changes rollout, saying GPs have been left in the dark.
Wegovy launches in Australia The manufacturer assured GPs supply planning has been its priority amid critical Ozempic shortages, but concerns remain over Wegovy’s availability.
Calls for expansion of multidisciplinary pain management The latest pain report shines a light on the need for multidisciplinary programs to be scaled up, in a bid to increase access and reduce stigma.